-
House Censures Rashida Tlaib, Citing ‘River to the Sea’ Slogan
Twenty-two Democrats joined most Republicans in the rebuke of Ms. Tlaib, the only Palestinian American in Congress, accusing her of calling for the destruction of Israel.
-
House Republicans Toil for a Spending Strategy With a Shutdown Close at Hand
Speaker Mike Johnson is facing many of the same challenges his predecessor did as he looks for a way to avoid a government shutdown that will be acceptable to his deeply divided conference.
-
Where Trump Counties in Ohio Voted to Support Abortion Rights
Ohio’s referendum drew support from both liberal and conservative areas of the state, and polled well ahead of President Biden’s results three years ago.
-
As Pandas Leave D.C., Is Panda Diplomacy Over?
The giant pandas are leaving Washington. Some fans find it unbearable.
-
A Federal Right of Publicity for the Age of AI? Unpacking the Proposed NO FAKES Act
Artificial intelligence-generated deepfakes—video, audio, or photographic content that mimics some or all of the characteristics of one’s identity—have captured the wary attention of the public, politicians and the entertainment industry, among others. While copyright laws have been frequently invoked when considering generative AI training and outputs, concerns have been raised about whether current state right…
-
Early Responses to Proposed AI Regulation
As a follow up to last week’s article about the Biden executive order on artificial intelligence (AI), this is a brief overview of one of its provisions that has proven to be controversial — namely, the additional scrutiny that the government plans for AI models and computing clusters over a certain size. The order states that the Secretary of…
-
Gene Therapy Approvals Gain Steam in 2023: Milestones Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather than focusing on treating or reducing symptoms. Currently, gene therapies are being developed for treatment of inherited diseases, autoimmune diseases, cancer, and infectious diseases. In July 2023, we posted about a series of FDA approvals…
-
New Artificial Intelligence Executive Order Contains Numerous Healthcare Implications
President Joe Biden on Oct. 30, 2023, signed a sweeping executive order (EO) and invoked the Defense Production Act to establish the first set of standards for using artificial intelligence (AI) in healthcare and other industries. The rise of the internet dramatically changed healthcare, and AI is poised to do the same. The rapid expansion of AI across healthcare……By:…
-
In Amended Complaint, FTC Alleges Kochava, a Data Broker, Is Collecting, Using and Disclosing “Massive Amounts” of Precise Geolocation Data
The Federal Trade Commission (FTC) has long expressed a concern about the potential misuse of location data. For example, in a 2022 blog post, “Location, health, and other sensitive information: FTC committed to fully enforcing the law against illegal use and sharing of highly sensitive data,” the agency termed the entire location data ecosystem “opaque”…
-
PJ&A Announces Data Breach Affecting the Information of an Unknown Number of Consumers
On November 3, 2023, Perry Johnson & Associates (“PJ&A”) filed a notice of data breach with the Attorney General of California after discovering that an unauthorized party was able to access files stored on the company’s computer network. In this notice, PJ&A explains that the incident resulted in an unauthorized party being able to access…
